Skip to main content
. 2012 Aug 3;7(8):e42134. doi: 10.1371/journal.pone.0042134

Table 5. Plasma insulin, adiponectin, leptin, TG and cholesterol levels at the end of treatment.

Treatment Insulin (ng/mL) AdipQ (µg/mL) Leptin (ng/mL) TG (mg/dL) Total cholesterol (mg/dL)
Lean 0.51±0.08* 24.0±1.3 7.21±0.51* 273±15* 92±2*
DIO Veh 2.92±0.46 21.2±0.9 32.47±1.20 178±9 158±4
CB1 ASO 25 mg/kg/wk 0.69±0.09* 25.9±1.1* 21.95±1.88* 189±18 111±4*
CB1 ASO 12.5 mg/kg/wk 1.73±0.35 23.9±1.1 30.73±1.34 196±13 141±5*
CB1 ASO 6.25 mg/kg/wk 2.04±0.38 21.4±1.0 30.93±1.73 193±21 147±6
Control ASO 25 mg/kg/wk 2.13±0.45 25.5±0.4* 32.80±1.11 195±16 170±4

Values shown are mean ± se. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.